| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 13, 2007
Revised on September 10, 2007
Accepted on September 13, 2007
From the Laboratory of Cardiovascular Science (X.G., K.-H.C., R.-P.X.), National Institute on Aging, NIH, Baltimore, Md; Institute of Cardiovascular Science (K.-H.C., Y.G., J.T.), Peking University, Beijing, People’s Republic of China; and Center for Molecular Cardiology (X.G., H.L.), Department of Cardiology, Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology, Wuhan, People’s Republic of China.
* To whom correspondence should be addressed. E-mail: chenku{at}grc.nia.nih.gov.
Abstract–Previous studies have shown that mitofusin 2 (Mfn-2) (or hyperplasia suppressor gene [HSG]) inhibits vascular smooth muscle cell (VSMC) proliferation. Here, we demonstrate that Mfn-2 is a primary determinant of VSMC apoptosis. First, oxidative stress with H2O2, inhibition of protein kinase C with staurosporine, activation of protein kinase A with forskolin, and serum deprivation concurrently elevate Mfn-2 expression and induce VSMC apoptosis. Second, overexpression of Mfn-2 also triggers apoptosis of VSMCs in culture and in balloon-injured rat carotid arteries, thus contributing to Mfn-2–mediated prevention of neointima formation after angioplasty. Third, Mfn-2 silencing protects VSMCs against H2O2 or Mfn-2 overexpression–induced apoptosis, indicating that upregulation of Mfn-2 is necessary and sufficient for oxidative stress–mediated VSMC apoptosis. The Mfn-2 proapoptotic effect is independent of its role in mitochondrial fusion but mainly mediated by inhibition of Akt signaling and the resultant activation of the mitochondrial apoptotic pathway, as manifested by decreased Akt phosphorylation, increased mitochondrial Bax/Bcl-2 ratio, cytochrome c release, and activation of caspases-9 and caspase-3. Furthermore, Mfn-2–induced apoptosis was blocked by overexpression of an active phosphoinositide 3-kinase mutant or Bcl-xL or inhibition of caspase-9 but not caspases-8. Thus, in addition to its antiproliferative effects, Mfn-2 constitutes a primary determinant of VSMC apoptosis.
This article has been cited by other articles:
![]() |
Y.-L. Huang, C.-M. Wu, G.-Y. Shi, G. C.-C. Wu, H. Lee, M.-J. Jiang, H.-L. Wu, and H.-Y. Yang Nestin Serves as a Prosurvival Determinant that is Linked to the Cytoprotective Effect of Epidermal Growth Factor in Rat Vascular Smooth Muscle Cells J. Biochem., September 1, 2009; 146(3): 307 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, A. T. Whaley-Connell, J. Habibi, J. Rehmer, N. Rehmer, K. Patel, M. Hayden, V. DeMarco, C. M. Ferrario, J. A. Ibdah, et al. Mineralocorticoid Receptor Antagonism Attenuates Vascular Apoptosis and Injury via Rescuing Protein Kinase B Activation Hypertension, February 1, 2009; 53(2): 158 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-F. Suen, K. L. Norris, and R. J. Youle Mitochondrial dynamics and apoptosis Genes & Dev., June 15, 2008; 22(12): 1577 - 1590. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |